EP14.05 LYMPH NODE METASTASIS IN MYXOPAPILLARY EPENDYMOMA WITHOUT CNS INVOLVEMENT: A RARE CASE REPORT AND THERAPEUTIC RESPONSE

Abstract BACKGROUND Myxopapillary ependymomas are rare neoplastic tumors originating from ependymal glial cells of the spinal cord. They rarely metastasize but may exhibit malignant behavior characterized by distant neural dissemination and spinal drop metastases. MATERIAL AND METHODS This is a retrospective case report of an adult patient with extra-neural metastatic myxopapillary ependymoma, including his diagnosis, treatment, and clinical outcomes. RESULTS We report the case of a 44-year-old male who presented with non-specific lower back pain for over 20 years, associated with gradual tumor growth. A near-total sacral resection was performed, and one year later, local recurrence was identified, without cerebrospinal fluid infiltration but with extra-neural metastases involving bilateral inguinal, pelvic, and retroperitoneal lymph nodes. Biopsy of an inguinal lymph node confirmed metastatic myxopapillary ependymoma. The patient underwent radiotherapy with a total dose of 36 Gy to the primary site and involved lymph nodes, followed by a sequential boost to 54 Gy to areas of gross disease, delivered with concurrent cisplatin. Adjuvant chemotherapy with cisplatin and etoposide (CDDP/VP-16) was administered. A PET-CT performed one year after treatment showed a partial response, with no further dissemination and good control of both neural and extra-neural disease. The patient remains under multidisciplinary follow-up and continues physiotherapy. CONCLUSION This case highlights a rare presentation of myxopapillary ependymoma with lymphatic metastasis in the absence of CNS dissemination. It underscores the potential efficacy of combined modality treatment, including systemic therapy, in controlling aggressive variants of this tumor.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-10-01
DOI
https://doi.org/10.1093/neuonc/noaf193.636
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EP14.05 LYMPH NODE METASTASIS IN MYXOPAPILLARY EPENDYMOMA WITHOUT CNS INVOLVEMENT: A RARE CASE REPORT AND THERAPEUTIC RESPONSE

Alejandro Rodríguez-Camacho, Bernardo Cacho‐Díaz, Gervith Reyes-Soto, Daniel Alejandro Vega-Moreno et al.
Neuro-Oncology
Glioma Diagnosis and Treatment
article

EP14.05 LYMPH NODE METASTASIS IN MYXOPAPILLARY EPENDYMOMA WITHOUT CNS INVOLVEMENT: A RARE CASE REPORT AND THERAPEUTIC RESPONSE

Alejandro Rodríguez-Camacho, Bernardo Cacho‐Díaz, Gervith Reyes-Soto, Daniel Alejandro Vega-Moreno, Óscar Arrieta, Alejandro Gonzalez-Vazquez, Enrique Caballé‐Perez, Ana María Cano Valdéz, César Octavio Lara-Torres, Mónica Serrano-Murillo, A.O. Chávez-Martínez, B E Lazo-Poveda
article en

Abstract

Abstract BACKGROUND Myxopapillary ependymomas are rare neoplastic tumors originating from ependymal glial cells of the spinal cord. They rarely metastasize but may exhibit malignant behavior characterized by distant neural dissemination and spinal drop metastases. MATERIAL AND METHODS This is a retrospective case report of an adult patient with extra-neural metastatic myxopapillary ependymoma, including his diagnosis, treatment, and clinical outcomes. RESULTS We report the case of a 44-year-old male who presented with non-specific lower back pain for over 20 years, associated with gradual tumor growth. A near-total sacral resection was performed, and one year later, local recurrence was identified, without cerebrospinal fluid infiltration but with extra-neural metastases involving bilateral inguinal, pelvic, and retroperitoneal lymph nodes. Biopsy of an inguinal lymph node confirmed metastatic myxopapillary ependymoma. The patient underwent radiotherapy with a total dose of 36 Gy to the primary site and involved lymph nodes, followed by a sequential boost to 54 Gy to areas of gross disease, delivered with concurrent cisplatin. Adjuvant chemotherapy with cisplatin and etoposide (CDDP/VP-16) was administered. A PET-CT performed one year after treatment showed a partial response, with no further dissemination and good control of both neural and extra-neural disease. The patient remains under multidisciplinary follow-up and continues physiotherapy. CONCLUSION This case highlights a rare presentation of myxopapillary ependymoma with lymphatic metastasis in the absence of CNS dissemination. It underscores the potential efficacy of combined modality treatment, including systemic therapy, in controlling aggressive variants of this tumor.

Neuro-OncologyVol. 27(Supplement_3)
Instituto Nacional de Cancerología (MX)
Openalex Percentile: Top 62%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.